A proteomics approach to identify COPD-related changes in lung fibroblasts

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Proteomics

Background:

• Lung fibroblasts play a role in tissue repair, but their function in chronic obstructive pulmonary disease (COPD) is not fully understood.
• Comprehensive proteomic and transcriptomic comparisons between COPD and control fibroblasts are lacking.

Purpose of the Study:

• To investigate the role of lung fibroblasts in COPD pathology.
• To perform unbiased proteomic and transcriptomic analysis of COPD and control fibroblasts.

Main Methods:

• Cultured lung fibroblasts from 17 stage IV COPD patients and 16 controls.
• Proteomic analysis using LC-MS/MS and transcriptomic analysis via RNA sequencing.
• Differential expression analysis, pathway enrichment, and correlation studies.

Main Results:

• Identified 40 differentially expressed proteins (DEPs) and zero differentially expressed genes (DEGs) between COPD and control fibroblasts.
• Key DEPs include HNRNPA2B1 and FHL1; 13 DEPs are previously linked to COPD.
• Six DEPs related to telomere maintenance pathways correlated with the senescence marker LMNB1; no significant gene-protein expression correlation was observed.

Conclusions:

• Described 40 DEPs in COPD fibroblasts, highlighting HNRNPA2B1 as a novel research target.
• Findings support the utility of unbiased proteomics in COPD research.
• Protein and gene expression data provide distinct insights into COPD fibroblast biology.